Gene Expression Analysis Market Forecasts to 2028 – Global Analysis By Technology (Ribonucleic Acid Expression, Promoter Analysis), Product (Consumables, Instruments), End User (Research Centers, Biotechnology) and By Geography
According to Stratistics MRC, the Global Gene Expression Analysis market is accounted for $3.86 billion in 2020 and is expected to reach $8.76 billion by 2028 growing at a CAGR of 10.8% during the forecast period. Rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases are the major factors driving the market growth. However, high cost of instruments is restraining the market growth.
Gene expression analysis is described as the process of studying the way genes are transcribed to synthesize functional gene products — functional ribonucleic acid (RNA) species or protein products. Gene expression analysis of gene regulation provides insights into normal cellular processes, such as differentiation, and pathological or abnormal processes.
Based on product, the consumables segment is estimated to have a lucrative growth due to the increasing volume of genetic tests in drug discovery, biomarker discovery, and pharmacogenomics applications. The increasing installation of next-generation sequencing (NGS) and polymerase chain reaction (PCR) equipment worldwide will significantly boost the demand for consumables. By geography, North America is going to have high growth during forecast period due to development of gene therapy, focus on gene expression studies, government initiatives, and the availability of funding for NGS research in this region.
Some of the key players profiled in the Gene Expression Analysis Market include Thermo Fisher Scientific, Qiagen, Illumina, Bio-Rad Laboratories, F. Hoffmann-La Roche, Agilent Technologies, Affymetrix, GE Healthcare, Perkinelmer, Oxford Gene Technology, Luminex, Microarrays, Partek, Zyagen and Tecan.
Estimated Market Size in 2020:
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 8.76 billion
Tables, Graphs & Figures
Capacity, Process, Service, Technology, Product, End User, Sales Channel and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Low- to Mid- Plex
• Complementary Deoxyribonucleic Acid (cDNA) Synthesis & Conversion
• Data Analysis & Interpretation
• Sample Collection
• Gene Expression Profiling
• Bioinformatics Solutions
• Ribonucleic Acid (RNA) Expression
• Promoter Analysis
• Protein Expression & Posttranslational Modification Analysis
• Sanger Sequencing
• Other Products
End Users Covered:
• Academic Institutes and Research Centers
• Biotechnology & Microbiology
• Contract Research Organization
• Diagnostics/ Clinical Diagnostics
• Drug Discovery & Development
• Pharmaceutical and Biotech Companies
Sales Channels Covered:
• Direct Sales
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Gene Expression Analysis Market is majorly driven rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.
The pharmaceutical and biotech companies segment is growing at a highest CAGR owing to focus on developing targeted therapies, especially for the treatment of cancer, complex diseases, and rare genetic disorders.
North America dominated with a significant market share due to the presence of a significant number of key players, such as Thermo Fisher Scientific, in the region.
Asia Pacific market is growing at a highest CAGR owing to the rising interest of dominant players in emerging markets, such as China and India.
Key players in Gene Expression Analysis Market include Thermo Fisher Scientific, Qiagen, Illumina, Bio-Rad Laboratories, F. Hoffmann-La Roche, Agilent Technologies, Affymetrix, GE Healthcare, Perkinelmer, Oxford Gene Technology, Luminex, Microarrays, Partek, Zyagen and Tecan.
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.